[Corrections] Correction to Lancet Oncol 2023; 24: 1042–52

January, 01, 2024 | Select Oncology Journal Articles

Umemura Y, Orringer D, Junck L, et al. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial. Lancet Oncol 2023; 24: 1042–52—In this Article the funding statements in the summary and the acknowledgments have been corrected. These corrections have been made to the online version as of Oct 2, 2023.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy